The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $88.55

Today's change+2.22 +2.57%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $88.55

Today's change+2.22 +2.57%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

CME Group Inc crosses above 20-day moving average

CME Group Inc closed up sharply Friday, rallying (U.S.)$2.22 or 2.57% to (U.S.)$88.55 and crossing above its 20-day moving average. Shares have lost 1.45% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 6.33% during the last year.

Key company metrics

  • Open(U.S.) $87.76
  • Previous close(U.S.) $86.33
  • High(U.S.) $88.89
  • Low(U.S.) $86.96
  • Bid / Ask-- / --
  • YTD % change-2.26%
  • Volume3,014,756
  • Average volume (10-day)2,141,226
  • Average volume (1-month)1,973,755
  • Average volume (3-month)1,600,690
  • 52-week range(U.S.) $81.87 to (U.S.) $100.87
  • Beta0.88
  • Trailing P/E23.69×
  • P/E 1 year forward20.56×
  • Forward PEG1.68×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield2.71%
  • Trailing EPS(U.S.) $3.74
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+37.62%

Based on its net profit margin of 37.62%, CME Group Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:FinancialsIndustry:Investment Services

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue850820843841
Total other revenue--------
Total revenue850820843841
Gross profit--------
Total cost of revenue--------
Total operating expense334325335370
Selling / general / administrative249244247258
Research & development--------
Depreciation / amortization57585756
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total28223255
Operating income516495507472
Interest income (expense), net non-operating-28-29-32-29
Gain (loss) on sale of assets--------
Other--------
Income before tax516448524474
Income after tax360265330307
Income tax, total157183193167
Net income360265330307
Total adjustments to net income--------
Net income before extra. items360265330307
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items360265330307
Inc. avail. to common incl. extra. items360265330307
Diluted net income360265330307
Dilution adjustment--00--
Diluted weighted average shares338338337337
Diluted EPS excluding extraordinary itemsvalue per share1.060.780.980.91
Dividends per sharevalue per share0.500.500.502.47
Diluted normalized EPSvalue per share1.060.780.980.91